Last reviewed · How we verify
NCT04805177
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage
NA trial testing hematoma evacuation in Intracerebral Hemorrhage (ICH) in 11 participants. Completed in 31 July 2024.
31 December 2023
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 8 August 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 July 2024 |
| Sites | 2 locations across Switzerland |
Drugs / interventions tested
- hematoma evacuation
Conditions studied
- Intracerebral Hemorrhage (ICH) — all drugs for Intracerebral Hemorrhage (ICH) →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 85, any sex, with Intracerebral Hemorrhage (ICH). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this pilot study is to provide an assessment of safety and feasibility of early minimally invasive image guided endoscopic hematoma evacuation (within 24 hours of symptom onset) in patients suffering from intracerebral haemorrhage (ICH).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data From 121 Surgically Treated Participants From the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial.
Hollingworth M, Woodhouse LJ, Law ZK, Ali A, et al · · 2024 · cited 2× · PMID 38785451 · DOI 10.1227/neu.0000000000002961 -
Early minimally invasive image-guided eNdoscopic evacuation of iNTracerebral hemorrhage: a phase II pilot trial.
Hallenberger TJ, Fischer U, Ghosh N, Kuhle J, et al · · 2024 · cited 1× · PMID 39628893 · DOI 10.3389/fneur.2024.1484255
Verify or expand the search:
- PubMed search for NCT04805177
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04805177 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 15 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04805177.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing